APA (7th ed.) Citation

Albliwi, M., Zabor, E. C., Hanna, J., El-Asmar, J., Nurse, D. P., Bawwab, A., . . . Mustafa Ali, M. K. (2025, August). Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60 to 75 Years: A Propensity Score–Adjusted Cohort Study. Clinical lymphoma, myeloma and leukemia. https://doi.org/10.1016/j.clml.2025.08.016

Chicago Style (17th ed.) Citation

Albliwi, Moath, et al. "Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60 to 75 Years: A Propensity Score–Adjusted Cohort Study." Clinical Lymphoma, Myeloma and Leukemia Aug. 2025. https://doi.org/10.1016/j.clml.2025.08.016.

MLA (9th ed.) Citation

Albliwi, Moath, et al. "Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60 to 75 Years: A Propensity Score–Adjusted Cohort Study." Clinical Lymphoma, Myeloma and Leukemia, Aug. 2025, https://doi.org/10.1016/j.clml.2025.08.016.